Thyrocare Technologies Ltd
THYROCAREThyrocare Technologies Ltd
THYROCAREPrice Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
52.88 | 6.48 | 2.75% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
52.97 | 5.96 | 0.54% |
Forecast & Ratings
Detailed Forecastfrom 1 analyst
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Thyrocare Technologies Limited is a diagnostic chain company which offers a range of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases.
Investor Presentation
View olderPeers
Compare with peersApollo Hospitals Enterprise Ltd
Max Healthcare Institute Ltd
Global Health Ltd
Fortis Healthcare Ltd
Narayana Hrudayalaya Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ cr.
All values in ₹ cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 191.07 | 247.51 | 316.63 | 379.32 | 413.52 | 441.44 | 507.05 | 618.11 | 536.27 | 564.02 | ||||||||||
Raw Materials | 55.93 | 69.68 | 81.78 | 94.61 | 110.79 | 117.17 | 163.86 | 170.57 | 163.03 | 425.20 | ||||||||||
Power & Fuel Cost | 3.95 | 5.32 | 6.35 | 6.68 | 7.77 | 8.69 | 7.64 | 8.40 | 10.71 | |||||||||||
Employee Cost | 17.48 | 25.70 | 32.00 | 35.34 | 43.35 | 48.92 | 58.07 | 61.13 | 106.15 | |||||||||||
Selling & Administrative Expenses | 20.76 | 28.89 | 46.14 | 49.57 | 59.27 | 44.48 | 42.16 | 45.47 | 51.69 | |||||||||||
Operating & Other expenses | 12.17 | 17.33 | 50.17 | 27.59 | 27.50 | 48.01 | 51.70 | 67.74 | 72.56 | |||||||||||
EBITDA | 80.78 | 100.59 | 100.19 | 165.53 | 164.84 | 174.17 | 183.62 | 264.80 | 132.13 | 138.82 | ||||||||||
Depreciation/Amortization | 12.87 | 18.24 | 18.05 | 20.10 | 26.17 | 31.91 | 30.28 | 33.87 | 38.71 | 44.75 | ||||||||||
PBIT | 67.91 | 82.35 | 82.14 | 145.43 | 138.67 | 142.26 | 153.34 | 230.93 | 93.42 | 94.07 | ||||||||||
Interest & Other Items | 0.30 | 0.55 | 0.46 | 0.44 | 0.61 | 1.85 | 0.87 | 3.21 | 4.83 | 3.75 | ||||||||||
PBT | 67.61 | 81.80 | 81.68 | 144.99 | 138.06 | 140.41 | 152.47 | 227.72 | 88.59 | 90.32 | ||||||||||
Taxes & Other Items | 22.40 | 30.00 | 38.83 | 51.71 | 52.92 | 52.01 | 39.32 | 51.58 | 24.23 | 24.73 | ||||||||||
Net Income | 45.21 | 51.80 | 42.85 | 93.28 | 85.14 | 88.40 | 113.15 | 176.14 | 64.36 | 65.59 | ||||||||||
EPS | 9.60 | 9.94 | 7.98 | 17.36 | 15.99 | 16.74 | 21.41 | 33.30 | 12.16 | 12.39 | ||||||||||
DPS | 15.28 | 10.00 | 10.00 | 10.00 | 20.00 | 5.00 | 25.00 | 15.00 | 18.00 | 18.00 | ||||||||||
Payout ratio | 1.59 | 1.01 | 1.25 | 0.58 | 1.25 | 0.30 | 1.17 | 0.45 | 1.48 | 1.45 |
Company Updates
Peers & Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Thyrocare Technologies Ltd | 53.89 | 6.48 | 2.75% |
Apollo Hospitals Enterprise Ltd | 109.86 | 13.78 | 0.24% |
Max Healthcare Institute Ltd | 70.74 | 10.54 | 0.12% |
Global Health Ltd | 119.17 | 16.00 | — |
Price Comparison
Compare THYROCARE with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
High Pledged Promoter Holding
A significant proportion of promoter holdings is pledged
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Thyrocare Technologies Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
Nippon India SMALL CAP FUND DIRECT PLAN GROWTH PLAN GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 3.0219% | Percentage of the fund’s portfolio invested in the stock 0.23% | Change in the portfolio weight of the stock over the last 3 months -0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 147/218 (-5) |
Nippon India PHARMA FUND DIRECT PLAN GROWTH PLAN - GROWTH OPTION GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.9817% | Percentage of the fund’s portfolio invested in the stock 1.46% | Change in the portfolio weight of the stock over the last 3 months -0.29% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 24/36 (-1) |
ICICI PRUDENTIAL INDIA OPPORTUNITIES FUND DIRECT PLAN GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.8482% | Percentage of the fund’s portfolio invested in the stock 0.38% | Change in the portfolio weight of the stock over the last 3 months -0.12% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 63/86 (-9) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
Dividend Yield
Current dividend yield is 2.75%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹27.47 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateApr 20, 2023
Dividend/Share
₹18.00
Ex DateEx Date
Apr 20, 2023
Cash Dividend
Ex DateEx DateMay 11, 2022
Dividend/Share
₹15.00
Ex DateEx Date
May 11, 2022
Cash Dividend
Ex DateEx DateJun 17, 2021
Dividend/Share
₹15.00
Ex DateEx Date
Jun 17, 2021
Cash Dividend
Ex DateEx DateNov 12, 2020
Dividend/Share
₹10.00
Ex DateEx Date
Nov 12, 2020
Cash Dividend
Ex DateEx DateNov 21, 2019
Dividend/Share
₹5.00
Ex DateEx Date
Nov 21, 2019
News & Opinions
News Video
When Debt Gets Repaid, The Thyrocare Pledge Will Come Down: PharmEasy CEO Siddharth Shah
4 months ago•CNBC-TV18
Thyrocare - Stimulating Model To Restore Profitability: ICICI Securities
4 months ago•Bloomberg Quint
News Video
What's In Store For Diagnostic & Pharma Stocks? | BQ Prime
7 months ago•BQ Prime
Thyrocare franchise business doing well; to fund Africa expansion via internal accruals: MD
8 months ago•Economic Times
Thyrocare Technologies shares dip on weak Q1 results
8 months ago•The Hindu Businessline
News Video
Thyrocare Slips In Trade Despite Healthy Margin In Q1FY24 | CNBC TV18
8 months ago•CNBC-TV18
Thyrocare Tech tumbles 3% on weak Q1 earnings show
8 months ago•Moneycontrol
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 7.17%, vs industry avg of 13.8%
Decreasing Market Share
Over the last 5 years, market share decreased from 1.18% to 0.84%